Whitepaper: Analyzing tablets by NIR spectroscopy
Drug analysis needs to be costeffective without compromising on accuracy. Near-infrared spectroscopy is a useful part of the pharmaceutical analysis toolbox. This report illustrates two examples of what it can do…
Near-infrared spectroscopy allows the analysis of many physical and chemical parameters – simultaneously and within just a few seconds. Using two examples, this report illustrates what the technique can do for the pharmaceutical industry.
Drug analysis needs to be cost-effective without compromising on accuracy. This is an important principle for both routine quality control and the identification of potentially harmful counterfeit medicines.
Near-infrared spectroscopy, or NIRS for short, is a useful part of the pharmaceutical analysis toolbox – and a winning choice thanks to the minimal time and labour resources it consumes, as well as the fully automated online analyses it offers. Not only that, but it also takes simultaneous analysis of multiple substances in its stride.
This whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Related content from this organisation
- Metrohm acquires innovative Photonic Solutions to expand Handheld Raman portfolio
- Application Notes & Whitepapers 2017
- Whitepaper: Do you know what’s going in? Analysing tablets by NIR spectroscopy
- Whitepaper: Regulatory compliance in pharma – software requirements and solutions
- Metrohm & CAMO Software are announcing a global partnership